Katy Shaw-Saliba

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial”.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00751-9

N/A

6.2DataRank · unranked

194 citations

Uriel Sandkovsky, Cavan S. Reilly, David M. Vock, Robert L. Gottlieb, Michael Mack +95 more

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00215-6

N/A

4.5DataRank · unranked

128 citations

Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits +95 more

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198

N/A

0.439DataRank · unranked

13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

International Journal of Infectious Diseases(2024)10.1016/j.ijid.2024.106985

N/A

0DataRank · unranked

7 citations

Donatien Kazadi, Kadidia Kone, Viviane Callier, Djénéba Dabitao, Dehkontee Dennis +63 more

Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae452

N/A

0DataRank · unranked

0 citations

Eleftherios Mylonakis, Robin Dewar, Barnaby Edward Young, Jacqueline Nordwall, Sanjay Bhagani +37 more

A Coordinated Public Health Laboratory Response to COVID-19 in Mali

Frontiers in Tropical Diseases(2022)10.3389/fitd.2021.788616

N/A

0DataRank · unranked

4 citations

A. Koné, Ibréhima Guindo, Sidy Bane, Lassina Doumbia, Lassana Gadi Timbiné +39 more

Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia

medRxiv(2023)10.1101/2023.08.01.23293521

N/A

0DataRank · unranked

0 citations

Christina Lindan, Kumblytee Johnson, Cavan Reilly, Julie Blie, Katy Shaw-Saliba +7 more

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciad780

N/A

0DataRank · unranked

16 citations

Jacquie Nordwall, Dominique L. Braun, Lucy Chung, Jordan Coslet, Tatyana Der +93 more